Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net Income
-34.53M -17.02M -18.38M -16.91M
Depreciation & Amortization
6.3M 4.04M 1.14M 530.02K
Stock-Based Compensation
6.26M 7.89M 7.09M 1.66M
Other Working Capital
963K -4.87M -2.47M -877.09K
Other Non-Cash Items
7.3M 1.47M 37.74K 22.07K
Deferred Income Tax
-1.31M -2.36M -285.55K 180.13K
Change in Working Capital
n/a -5.7M -3.88M -1.72M
Operating Cash Flow
-15.97M -11.67M -14.28M -16.24M
Capital Expenditures
-4.65M -1.03M -526.17K -16.79K
Cash Acquisitions
-23.96M -24.3M -71.4M 20.4K
Purchase of Investments
n/a -130.55M n/a n/a
Sales Maturities Of Investments
42.77M -127.79M n/a n/a
Other Investing Acitivies
-12.59M 127.79M 225.00 1M
Investing Cash Flow
1.58M -155.88M -71.93M 1.01M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 8K 19.63M 20.22M
Financial Cash Flow
n/a 8K 219.16M 76.71M
Net Cash Flow
-14.45M -167.55M 132.96M 61.48M
Free Cash Flow
-20.62M -12.7M -14.8M -16.26M